Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer
Yahoo
Mon, 06/6/16 - 10:31 am
Tags:
Lynparza, olaparib, ovarian cancer, AstraZeneca, ASCO 2016
AZ jilts gout med Zurampic with $230M rights sale to Grunenthal
Fierce Pharma
Thu, 06/2/16 - 04:03 pm
Tags:
AstraZeneca, gout, Zurampic, Grunenthal
AstraZeneca discontinues 'Take it From a Fish' ad campaign
BioPharma Dive
Thu, 06/2/16 - 09:56 am
Tags:
AstraZeneca, drug ads
What’s AstraZeneca’s Largest Revenue Contributor?
Yahoo/Market Realist
Wed, 06/1/16 - 04:43 pm
Tags:
AstraZeneca, Cardiovascular
Bet You Can't Guess Which of These 10 Big Pharma Names Has the Largest Late-Stage Pipeline
Motley Fool
Mon, 05/30/16 - 10:13 am
Tags:
JNJ, Pfizer, Novartis, Merck, Bristol-Myers Squibb, GSK, Sanofi, AbbVie, Eli Lilly, AstraZeneca
A Great Month For Relypsa
Seeking Alpha
Sat, 05/28/16 - 10:38 am
Tags:
Relypsa, AstraZeneca, Veltassa, hyperkalemia, ZS-9
AstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA
Yahoo/Benzinga
Fri, 05/27/16 - 12:42 pm
Tags:
AstraZeneca, FDA, ZS-9, hyperkalaemia, ZS Pharma
GSK, AZ hit with deep price cuts in China on key drugs
Fierce Pharma
Fri, 05/20/16 - 11:50 am
Tags:
GSK, AstraZeneca, China, drug pricing
Pascal Soriot's big experiment: reinventing AstraZeneca
Yahoo/Reuters
Wed, 05/18/16 - 11:10 am
Tags:
Pascal Soriot, AstraZeneca
AstraZeneca Announces Positive Results from Benralizumab Phase III Program in Severe Asthma
Yahoo
Tue, 05/17/16 - 09:51 am
Tags:
AstraZeneca, asthma, severe asthma, benralizumab
AstraZeneca looks to DNA damage-response drugs for edge in oncology
BioPharma Dive
Tue, 05/17/16 - 09:25 am
Tags:
AstraZeneca, oncology, ASCO, Lynparza
3 Big Pharma Stocks With Credible Threats to Their Blockbusters
24/7 Wall St
Fri, 05/6/16 - 10:52 am
Tags:
Pfizer, renal cancer, Sutent, cabozantinib, Exelixis, AstraZeneca, Faslodex, breast cancer, Atossa Genetics, Merck, Zetia, Mylan Labs
Takeda renames antidepressant after name confusion leads to errors
BioPharma Dive
Tue, 05/3/16 - 09:49 pm
Tags:
Takeda, antidepressants, drug names, Brintellix, AstraZeneca, Brilinta
Medivation: Why a Takeover Just Got a Little Tougher
Barron's
Mon, 05/2/16 - 10:03 pm
Tags:
Medivation, M&A, Sanofi, Pfizer, AstraZeneca
Crestor tumbles off patent cliff as first generic copy approved in US
BioPharma Dive
Mon, 05/2/16 - 10:09 am
Tags:
Crestor, patents, patent cliff, generics, AstraZeneca, Watson Pharmaceuticals
Pfizer and AstraZeneca might create some headache for Sanofi in its attempts to buy the biotech company Medivation
Bidness, ETC
Mon, 05/2/16 - 10:03 am
Tags:
Pfizer, Sanofi, Medivation, AstraZeneca, M&A
AstraZeneca, Pfizer Said Among Firms Weighing Medivation Bid
Bloomberg
Sat, 04/30/16 - 11:45 am
Tags:
AstraZeneca, Pfizer, Sanofi, Medivation, M&A
AstraZeneca Gains on New Cost-Cutting Plans
Bidness, ETC
Fri, 04/29/16 - 10:57 am
Tags:
AstraZeneca, earnings
AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million
BioPharma Dive
Wed, 04/27/16 - 02:11 pm
Tags:
AstraZeneca, Zurampic, Ironwood Pharmaceuticals, gout
AstraZeneca launches massive drug discovery effort, aims to sequence 2 million genomes
BioPharma Dive
Fri, 04/22/16 - 11:06 am
Tags:
AstraZeneca, genome sequencing, drug discover, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.